GlassScriptPhysician profile
Vy Ngo
NPI 1508463571
$4,685.48
in general payments reported to CMS, 2019-2025
19 companies · $900 in 2025
The $900 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.25 · 2022: $581 · 2023: $1,271 · 2024: $1,918 · 2025: $900.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,835 · Education: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,834.85 |
| Education | $254.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,264.66 | 2022-2025 | |
| Janssen Biotech, INC. | $774.56 | 2023-2025 | Tremfya |
| Amgen INC. | $628.16 | 2022-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $424.77 | 2022-2024 | Dupixent, Libtayo |
| Arcutis Biotherapeutics, INC. | $292.19 | 2024-2025 | Zoryve |
| Lilly USA, LLC | $202.59 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Revance Therapeutics, INC. | $188.80 | 2024 | Daxxify |
| Ucb, INC. | $180.52 | 2023-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $156.98 | 2022-2024 | |
| Genzyme Corporation | $137.31 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $100.54 | 2024-2025 | Sotyktu |
| Organon LLC | $99.03 | 2025 | |
| Mayne Pharma Commercial LLC | $77.06 | 2022 | |
| Incyte Corporation | $58.06 | 2021-2022 | |
| Galderma Laboratories, L.P. | $25.60 | 2022-2025 | Nemluvio |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $22.77 | 2025 | |
| Dermavant Sciences, INC. | $19.75 | 2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.66 | 2022 | |
| Leo Pharma INC. | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vy Ngo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.